The first ever avian influenza vaccine recently started trials in the UK. This marks a milestone in the prevention of bird flu infections in humans. The vaccine targets the H5N1 flu strain, which ...
Innovative approach expands drug discovery possibilities for targets beyond the reach of conventional methodTo be presented ...
Enzymes are proteins that catalyze chemical reactions in living organisms. They are widely applied in industries such as food ...
ExploRNA Therapeutics’ biologically inspired, ground-breaking technologies are enabling more precise customization of mRNA constructs with advanced vaccine and therapeutic applications. Research based ...
The development of nucleic-acid therapeutics, ranging from aptamers and antisense RNA to messenger RNA (mRNA)-based vaccines and gene therapies, is a rapidly evolving industry that has the potential ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes ...
Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.
For R&D leaders evaluating AI investments, I’d offer one piece of advice: Before spending more on models, look hard at your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results